Nobori Drug Eluting Stent is indicated for improving luminal diameter and reducing in-stent restenosis for the treatment of coronary artery lesions. Nobori stent has an innovative design, with biolimus A9 drug and biodegradable polymer, coated only on the abluminal side of the stent. This technology provides efficacy and preserves safety over time.
Carna Code | 00100068000290 |
Manufacturer | Terumo Corporation |
Product Code | - |
Description | - |
Biological Category | Non Biological Product |
Certification | - |
GTIN | - |
Packaging Size | 1 Piece(s) |
MRP(INR) | |
Classification | Medical Materials >> Patient >> Specific Organ >> Cardiology >> Cardiovascular System >> Heart >> Percutaneous Transluminal Coronary Angioplasty >> Stent |
Plans to launch health support service for expatriates!
We implemented the collaboration with YOKUMIRU Corp, and we plan to launch Telehealth second opinion services for expatriates from December 2023.